Novo Nordisk shares slump after drug failure in Alzheimer’s trial

All NewsNovember 24, 2025

Outcome is blow to one of Europe’s largest listed companies

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent